Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Jerzy, Korewicki"'
Autor:
Barbara Wizner, Małgorzata Fedyk-Łukasik, Grzegorz Opolski, Tomasz Zdrojewski, Adam Windak, Marcin Czech, Jacek S. Dubiel, Michał Marchel, Krzysztof Rewiuk, Tomasz Rywik, Jerzy Korewicki, Tomasz Grodzicki
Publikováno v:
European Journal of General Practice, Vol 24, Iss 1, Pp 1-8 (2018)
Background: Organizational and educational activities in primary care in Poland have been introduced to improve the chronic heart failure (CHF) management. Objectives: To assess the use of diagnostic procedures, pharmacotherapy and referrals of CHF i
Externí odkaz:
https://doaj.org/article/aafd1e49052044f0827b6cf288857189
Autor:
Witold Smigielski, Małgorzata Sobieszczańska-Małek, Tomasz Zieliński, Tomasz Rywik, Grazyna Jerzak-Wodzynska, Paula Polaska, Janusz Gajda, Jerzy Korewicki, Piotr Rozentryt
Publikováno v:
Acta cardiologica. 76(5)
The prognosis of patients with advanced heart failure is unfavourable. However, little is known about the survival of patients referred for heart transplantation but finally disqualified from transplantation due to contraindications. This study aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdb65d2155783b268864a4cea1212f74
https://pubmed.ncbi.nlm.nih.gov/33432873
https://pubmed.ncbi.nlm.nih.gov/33432873
Autor:
Wiesława Grajkowska, Maria Kaczorowska, Mariusz Kuśmierczyk, Przemysław Leszek, Małgorzata Karczmarz, Adam Parulski, Grzegorz Małek, Tomasz Zieliński, Maciej Pronicki, Małgorzata Sobieszczańska-Małek, Sylwia Szymańska, Krzysztof Komuda, Paweł Bekta, Jerzy Korewicki, Alicja Cicha-Mikołajczyk
Publikováno v:
Annals of Transplantation
BACKGROUND The aim of this study was to find the main risk factors for development of cardiac allograft vasculopathy (CAV), especially factors identified before the surgical procedure and factors related to the recipient profile and the medical histo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5dc82a1e123096306befe110c151bfa
https://doi.org/10.12659/aot.905267
https://doi.org/10.12659/aot.905267
Autor:
Przemysław Leszek, Piotr Rozentryt, G Jerzak-Wodzynska, J Gajda, T. Rywik, P Polaska, Tomasz Zieliński, Jerzy Korewicki, W Smigielski
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cba8baa31dc9f2cfd8f834317d77f9a5
https://doi.org/10.1093/eurheartj/ehy563.p4717
https://doi.org/10.1093/eurheartj/ehy563.p4717
Publikováno v:
Kardiologia Polska. 73:387-395
Background: Heart transplantation (HTx) is still the optimal treatment for refractory heart failure (HF). However, there is great disproportion between the number of donors and potential recipients. Several parameters are used in patient evaluation b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d4c742d3263d202fc3a7be61f3dd2fc
https://doi.org/10.5603/kp.a2014.0245
https://doi.org/10.5603/kp.a2014.0245
Autor:
Tomasz Zdrojewski, Barbara Wizner, Tomasz Rywik, Małgorzata Fedyk-Łukasik, Jerzy Korewicki, Jacek S. Dubiel, Krzysztof Rewiuk, Michał Marchel, Marcin Czech, Tomasz Grodzicki, Grzegorz Opolski, Adam Windak
Publikováno v:
The European Journal of General Practice
European Journal of General Practice, Vol 24, Iss 1, Pp 1-8 (2018)
European Journal of General Practice, Vol 24, Iss 1, Pp 1-8 (2018)
Background: Organizational and educational activities in primary care in Poland have been introduced to improve the chronic heart failure (CHF) management. Objectives: To assess the use of diagnostic procedures, pharmacotherapy and referrals of CHF i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::813f806e2007bac0e975fb22316af9d1
Autor:
Małgorzata Sobieszczańska-Małek, Tomasz Zieliński, Walerian Piotrowski, Jerzy Korewicki, On behalf of the participants Of POLKARD-HF
Publikováno v:
Cardiology Journal. 21:532-538
Pulmonary hypertension is a contradiction for heart transplantation (HTx). The aim of the study was to examine prognostic significance of pulmonary hemodynamic variables in patients with severe chronic heart failure (HF) considered for HTx.Patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b8dce2693fac7d795ebcf591bc9b8b8
https://doi.org/10.5603/cj.a2014.0015
https://doi.org/10.5603/cj.a2014.0015
Autor:
Jerzy Korewicki, Tomasz Zieliński, Tomasz Rywik, Walerian Piotrowski, Przemysław Leszek, Piotr Rozentryt, Grażyna Broda, Jacek Koziarek
Publikováno v:
Polish Archives of Internal Medicine. 123:664-671
INTRODUCTION Data regarding standardized trends in mortality from heart failure (HF) in the general population are limited. OBJECTIVES The aim of the study was to evaluate trends in HF mortality in Poland in the years 1980-2010. PATIENTS AND METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e2abdc6753c94fbc396feb930e15aec
https://doi.org/10.20452/pamw.2007
https://doi.org/10.20452/pamw.2007
Autor:
Lawrence I. Deckelbaum, Orlando F. Bueno, Piotr Ponikowski, Waldemar Radziszewski, Aldo P. Maggioni, Jacek Grzybowski, Atalanta Ghosh, Stephen J. Greene, Ayan R. Patel, Allan Olson, Cezar Macarie, Marco Metra, Mihai Gheorghiade, Andreas Koester, Serban I. Bubenek-Turconi, Marvin A. Konstam, Jerzy Korewicki, Lilian Y. Li
Publikováno v:
European Journal of Heart Failure. 15:679-689
Aims Human stresscopin is a corticotropin-releasing factor (CRF) type 2 receptor (CRFR2) selective agonist and a member of the CRF peptide family. Stimulation of CRFR2 improves cardiac output and left ventricular ejection fraction (LVEF) in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7ca42866205dd39b4d5abc8d78c0b66
https://doi.org/10.1093/eurjhf/hft023
https://doi.org/10.1093/eurjhf/hft023
Autor:
Jerzy, Korewicki, Przemysław, Leszek, Tomasz, Zieliński, Tomasz, Rywik, Walerian, Piotrowski, Paweł, Kurjata, Katarzyna, Kozar-Kamińska, Katarzyna, Kodziszewska, Krzysztof, Roguski
Publikováno v:
Cardiology Journal. 19:36-44
Based on the results of clinical trials, the prognosis for patients with severe heart failure (HF) has improved over the last 20 years. However, clinical trials do not reflect 'real life' due to patient selection. Thus, the aim of the POLKARD-HF regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a8c71f8c3087039d56853c7fa1b9e8
https://doi.org/10.5603/cj.2012.0007
https://doi.org/10.5603/cj.2012.0007